SCHEMBL21029563

SCHEMBL21029563

CCC(C)(C)c1ccc(OC(=O)OC)c(C(C)(C)C)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.50
MAPK1 P28482 4/20 0.50
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
NPSR1 Q6W5P4 3/20 0.50
ALDH1A1 P00352 2/20 0.50
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
LMNA P02545 1/20 0.40
CASP3 P42574 1/20 0.40
ATM Q13315 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
ACACB O00763 1/20 0.39
APEX1 P27695 1/20 0.39
HTT P42858 4/20 0.38
MAPT P10636 3/20 0.38
UBE2N P61088 2/20 0.38
GLA P06280 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27262693 0.89 SMN1; SMN2 (0.50) SMN1; SMN2MAPK1MEN1KMT2ANPSR1
SCHEMBL377171 0.86 APEX1 (0.48) SMN1; SMN2MAPK1MEN1KMT2ANPSR1
SCHEMBL29798808 0.86 APEX1 (0.48) SMN1; SMN2MAPK1MEN1KMT2ANPSR1
SCHEMBL1953482 0.85 MAPK1 (0.62) SMN1; SMN2MAPK1MEN1KMT2ANPSR1
SCHEMBL5947663 0.81 APEX1 (0.47) SMN1; SMN2MAPK1MEN1KMT2ANPSR1
SCHEMBL28378699 0.79 MAPK1 (0.59) SMN1; SMN2MAPK1MEN1KMT2ANPSR1
SCHEMBL2976214 0.79 HTT (0.39) SMN1; SMN2MEN1KMT2AALDH1A1LMNA
SCHEMBL784634 0.79 MEN1 (0.43) SMN1; SMN2MAPK1MEN1KMT2ANPSR1
SCHEMBL20219215 0.79 MEN1 (0.41) SMN1; SMN2MAPK1MEN1KMT2ANPSR1
SCHEMBL12353579 0.79 NPSR1 (0.46) SMN1; SMN2MAPK1MEN1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2951158-B1 PROCESS FOR THE PREPARATION OF IVACAFTOR AND SOLVATES THEREOF GLENMARK PHARMACEUTICALS LTD (IN) 2019-05-29 EP disclosed